Navigation

Biomedical applications

New nanomaterials can lead to pioneering developments in pharmacology, medical testing and medical equipment. Synthetic medicines based on nanoparticles maylead to a new generation of multifunctional drugs. A further area of application are implants or bone-substitute materials whose mechanical and immunological properties can be optimised thanks to nanoparticles. In all cases, nanoparticles can enter the body, which could cause unintended effects. Both opportunities and their concomitant risks need to be investigated.

 Completed projects

 

 

Biomedical nanoparticles as immunomodulatorsBiomedical nanoparticles as immunomodulatorshttp://www.nfp64.ch/en/projects/module-biomedical-applications/project-rothen-rutishauserProf. Barbara Rothen-Rutishauser
Developing non-degradable, more resistant bone replacement materialsDeveloping non-degradable, more resistant bone replacement materialshttp://www.nfp64.ch/en/projects/module-biomedical-applications/project-luginbuehlDr. Reto Luginbühl
Distribution and impact of nanoparticles from biodegradable implantsDistribution and impact of nanoparticles from biodegradable implantshttp://www.nfp64.ch/en/projects/module-biomedical-applications/project-frenzProf. Martin Frenz
Efficient blood purification with the help of magnetic nanoparticlesEfficient blood purification with the help of magnetic nanoparticleshttp://www.nfp64.ch/en/projects/module-biomedical-applications/project-beck-schimmerProf. Beatrice Beck Schimmer
Health risks from the inhalation of nanoparticles in smokeHealth risks from the inhalation of nanoparticles in smokehttp://www.nfp64.ch/en/projects/module-biomedical-applications/project-riedikerDr. Michael Riediker
New nanoparticles for efficient and safe interaction with cells and virusesNew nanoparticles for efficient and safe interaction with cells and viruseshttp://www.nfp64.ch/en/projects/module-biomedical-applications/project-stellacciProf. Francesco Stellacci
Risk analysis of inhaled nanoparticles with an in-vitro technologyRisk analysis of inhaled nanoparticles with an in-vitro technologyhttp://www.nfp64.ch/en/projects/module-biomedical-applications/project-geiser-kamberProf. Marianne Geiser Kamber
Transporting nanoparticles through the human placentaTransporting nanoparticles through the human placentahttp://www.nfp64.ch/en/projects/module-biomedical-applications/project-wickDr. Peter Wick

Further information on this content